default author photo

Ying Liu

The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases

SCHOLARLY PAPERS

1

DOWNLOADS

75

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal Delns1-nCoV-RBD LAIV for COVID-19 in Healthy Adults

Number of pages: 32 Posted: 20 Jun 2022
The University of Hong Kong - Li Ka Shing Faculty of Medicine, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - Clinical Trials Centre, The University of Hong Kong - AIDS Institute, The University of Hong Kong - AIDS Institute, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Queen Mary Hospital, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases and The University of Hong Kong - School of Clinical Medicine
Downloads 75 (837,727)

Abstract:

Loading...

Phase-1, intranasal, DelNS1-nCoV-RBD LAIV, COVID-19